Gross-Fengels W, Neufang K F, Lechler E, Schmitz-Rixen T
Radiologisches Institut der Universität zu Köln.
Rofo. 1988 Mar;148(3):269-74. doi: 10.1055/s-2008-1048191.
We report the results of a 2-phase urokinase protocol for treatment of 28 arterial occlusions of the lower extremities. 26 patients, aged 43-86, with up to 6 weeks old occlusions were treated. In Phase I (average duration 2.7 h) the urokinase solution was injected in intervals directly into the occlusion-material via a F-5 catheter (120,000 U/h). In the following phase II (average duration 26.1 h) 100,000 U/h were given as a continuous arterial infusion and a full heparin regimen was started. In 86% of the treatments there was an improvement as shown by angiography. 75% of the patients could be released from the hospital without a further surgical revascularisation. Alterations of the systemic coagulation-system and bleeding-complications at the puncture site must be expected.
我们报告了一项分两阶段使用尿激酶治疗28例下肢动脉闭塞的方案的结果。对26例年龄在43 - 86岁、闭塞时间长达6周的患者进行了治疗。在第一阶段(平均持续时间2.7小时),通过F - 5导管(120,000单位/小时)将尿激酶溶液间隔直接注入闭塞物质中。在随后的第二阶段(平均持续时间26.1小时),以100,000单位/小时的速度进行持续动脉输注,并开始全面的肝素治疗方案。血管造影显示,86%的治疗有改善。75%的患者无需进一步手术血管重建即可出院。必须预期会出现全身凝血系统的改变和穿刺部位的出血并发症。